Zwi N Berneman, MD, PhD
Antwerp University Hospital, Division of Hematology and Center for Cell Therapy and Regenerative Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Zwi N Berneman, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:06 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05765084 · Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural MesotheliomaUniversity Hospital, Antwerp · recruiting · Malignant Pleural Mesothelioma · study director
- Ph1/Ph2NCT04911621 · Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine GliomaUniversity Hospital, Antwerp · completed · High Grade Glioma, Diffuse Intrinsic Pontine Glioma · principal investigator
- Ph1/Ph2NCT02649829 · Autologous Dendritic Cell Vaccination in MesotheliomaUniversity Hospital, Antwerp · completed · Malignant Pleural Mesothelioma · study director
- Ph1/Ph2NCT02649582 · Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma PatientsUniversity Hospital, Antwerp · active not recruiting · Glioblastoma Multiforme of Brain · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:06 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in diffuse midline glioma (dipg).